Physitrack PLC ("Physitrack" or the "Company") announces that, pursuant to the share buy-back programme announced on 21 July 2026, it has undertaken the following share repurchase transactions during the period 5 October 2026 to 9 October 2026 (the "Period").
Summary of transactions
| Period | Total shares repurchased during the week | Volume-weighted average price paid (SEK) | Total consideration paid (SEK) | Total shares held by the Company (treasury) following these transactions | Total outstanding shares in the Company | Treasury holding as % of issued share capital |
| 5 October 2026 - 9 October 2026 | 5,624 | 9.5507 | 53,713.10 | 54,713.10 | 16,260,766 | 0.3366% |
Individual transactions
The following is a detailed breakdown of the transactions on each trading day during the Period:
| Date | Quantity | Average price (SEK) |
| 2026-10-05 | 1,500 | 9.7997 |
| 2026-10-06 | 1,000 | 9.61 |
| 2026-10-07 | 1,500 | 9.46 |
| 2026-10-08 | 624 | 9.4081 |
| 2026-10-09 | 1,000 | 9.3429 |
The buy-back programme is conducted within the safe harbour provided by Article 5 of the Market Abuse Regulation (EU) No 596/2014 ("MAR") and Commission Delegated Regulation (EU) 2016/1052, for the purpose of meeting the Company's obligations under its employee share plans. All transactions are executed by Pareto Securities on a non-discretionary basis on Nasdaq First North Growth Market Stockholm.
Notification details
| 1. Issuer: | Physitrack PLC, LEI 213800PC4QYNWHPCP774 |
| 2. Instrument/ISIN: | Ordinary shares / GB00BYX22590 |
| 3. Trading venue: | Nasdaq First North Growth Market Stockholm (PTRK) |
| 4. Currency: | SEK |
| 5. Purpose of buy-back: | To meet the Company's obligations under its employee share plans (a permitted purpose under Article 5(2) of MAR) |
| 6. Executing broker: | Pareto Securities (non-discretionary mandate) |
This disclosure is made in accordance with Article 5(3) of MAR and Commission Delegated Regulation (EU) 2016/1052.